Showing results (471-480 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|July 5, 2025
Oral contraceptive use and risk of liver cancer: a population-based study, systematic review, and meta-analysisCody Z Watling, Siân Sweetland, Aika Wojt, et al.
The Lancet. Oncology|July 5, 2025
Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational studyJinming Li, Yedong Pan, Fanying Guo, et al.
The Lancet. Oncology|July 3, 2025
Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative GroupKatie M O'Brien, Melissa G House, Mandy Goldberg, et al.
The Lancet. Oncology|December 25, 2025
International consensus recommendations and alignment of terminology for the histopathological diagnosis of extranodal extension in head and neck squamous cell carcinoma: an HN-CLEAR initiativeRuta Gupta, Timothy Fielder, Munita Bal, et al.
The Lancet. Oncology|December 25, 2025
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessmentJasper K W Gerritsen, Philipp Karschnia, Lorenzo Bello, et al.
The Lancet. Oncology|December 22, 2025
O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trialAnca-Ligia Grosu, Wolfgang A Weber, Erika Graf, et al.
The Lancet. Oncology|April 3, 2025
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysisAndrew D J Pearson, Claudia Rossig, Crystal L Mackall, et al.
The Lancet. Oncology|May 10, 2025
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort studyEva Blondeaux, Amir Sonnenblick, Elisa Agostinetto, et al.
The Lancet. Oncology|May 11, 2025
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trialJian Zhou, Li Bai, Jia Luo, et al.
The Lancet. Oncology|April 26, 2025
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trialAziz Zaanan, Olivier Bouché, Christelle de la Fouchardière, et al.
Pageof 336